Selected research
Industry Research
Meso Scale Discovery (MSD) Assay Services Industry Research Report 2026
Market perspective
The global Meso Scale Discovery (MSD) Assay Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Meso Scale Discovery (MSD) Assay Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Meso Scale Discovery (MSD) Assay Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Meso Scale Discovery (MSD) Assay Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Meso Scale Discovery (MSD) Assay Services include Chimera Biotec, Reaction Biology, NorthEast BioAnalytical Laboratories LLC, Creative Proteomics, Pestka Biomedical Laboratories, Inc, Precision Medicine Group, LLC, CellCarta, ImmunoDiagnostics Limited and Alcyomics Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Meso Scale Discovery (MSD) Assay Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Meso Scale Discovery (MSD) Assay Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Meso Scale Discovery (MSD) Assay Services Market by Company
Chimera Biotec
Reaction Biology
NorthEast BioAnalytical Laboratories LLC
Creative Proteomics
Pestka Biomedical Laboratories, Inc
Precision Medicine Group, LLC
CellCarta
ImmunoDiagnostics Limited
Alcyomics Ltd
IMMUNOLOGIX
Novogene
Guidon Pharmaceutics
MEDx Translational Medicine Co., Ltd
Meso Scale Discovery (MSD) Assay Services Segment by Type
S-Plex Technology
V-Plex Technology
Other
Meso Scale Discovery (MSD) Assay Services Segment by Application
Pharmaceutical Research
Clinical Diagnostics
Biomarker Discovery
Others
Meso Scale Discovery (MSD) Assay Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meso Scale Discovery (MSD) Assay Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meso Scale Discovery (MSD) Assay Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meso Scale Discovery (MSD) Assay Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Meso Scale Discovery (MSD) Assay Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- S-Plex Technology
- V-Plex Technology
- Other
Applications
- Pharmaceutical Research
- Clinical Diagnostics
- Biomarker Discovery
- Others
Companies covered
- Chimera Biotec
- Reaction Biology
- NorthEast BioAnalytical Laboratories LLC
- Creative Proteomics
- Pestka Biomedical Laboratories, Inc
- Precision Medicine Group, LLC
- CellCarta
- ImmunoDiagnostics Limited
- Alcyomics Ltd
- IMMUNOLOGIX
- Novogene
- Guidon Pharmaceutics
- MEDx Translational Medicine Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Meso Scale Discovery (MSD) Assay Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 S-Plex Technology
- 2.2.3 V-Plex Technology
- 2.2.4 Other
- 2.3 Meso Scale Discovery (MSD) Assay Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Research
- 2.3.3 Clinical Diagnostics
- 2.3.4 Biomarker Discovery
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Meso Scale Discovery (MSD) Assay Services Breakdown Data by Type
- 3.1 Global Meso Scale Discovery (MSD) Assay Services Historic Market Size by Type (2021-2026)
- 3.2 Global Meso Scale Discovery (MSD) Assay Services Forecasted Market Size by Type (2027-2032)
4 Meso Scale Discovery (MSD) Assay Services Breakdown Data by Application
- 4.1 Global Meso Scale Discovery (MSD) Assay Services Historic Market Size by Application (2021-2026)
- 4.2 Global Meso Scale Discovery (MSD) Assay Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Meso Scale Discovery (MSD) Assay Services Market Perspective (2021-2032)
- 5.2 Global Meso Scale Discovery (MSD) Assay Services Growth Trends by Region
- 5.2.1 Global Meso Scale Discovery (MSD) Assay Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Meso Scale Discovery (MSD) Assay Services Historic Market Size by Region (2021-2026)
- 5.2.3 Meso Scale Discovery (MSD) Assay Services Forecasted Market Size by Region (2027-2032)
- 5.3 Meso Scale Discovery (MSD) Assay Services Market Dynamics
- 5.3.1 Meso Scale Discovery (MSD) Assay Services Industry Trends
- 5.3.2 Meso Scale Discovery (MSD) Assay Services Market Drivers
- 5.3.3 Meso Scale Discovery (MSD) Assay Services Market Challenges
- 5.3.4 Meso Scale Discovery (MSD) Assay Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Meso Scale Discovery (MSD) Assay Services Players by Revenue
- 6.1.1 Global Top Meso Scale Discovery (MSD) Assay Services Players by Revenue (2021-2026)
- 6.1.2 Global Meso Scale Discovery (MSD) Assay Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Meso Scale Discovery (MSD) Assay Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Meso Scale Discovery (MSD) Assay Services Head Office and Area Served
- 6.4 Global Meso Scale Discovery (MSD) Assay Services Players, Product Type & Application
- 6.5 Global Meso Scale Discovery (MSD) Assay Services Manufacturers Established Date
- 6.6 Global Meso Scale Discovery (MSD) Assay Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Meso Scale Discovery (MSD) Assay Services Market Size (2021-2032)
- 7.2 North America Meso Scale Discovery (MSD) Assay Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Meso Scale Discovery (MSD) Assay Services Market Size by Country (2021-2026)
- 7.4 North America Meso Scale Discovery (MSD) Assay Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Meso Scale Discovery (MSD) Assay Services Market Size (2021-2032)
- 8.2 Europe Meso Scale Discovery (MSD) Assay Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Country (2021-2026)
- 8.4 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size (2021-2032)
- 9.2 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Meso Scale Discovery (MSD) Assay Services Market Size (2021-2032)
- 10.2 South America Meso Scale Discovery (MSD) Assay Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Meso Scale Discovery (MSD) Assay Services Market Size by Country (2021-2026)
- 10.4 South America Meso Scale Discovery (MSD) Assay Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Meso Scale Discovery (MSD) Assay Services Market Size (2021-2032)
- 11.2 Middle East & Africa Meso Scale Discovery (MSD) Assay Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Meso Scale Discovery (MSD) Assay Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Meso Scale Discovery (MSD) Assay Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Chimera Biotec
- 12.1.1 Chimera Biotec Company Information
- 12.1.2 Chimera Biotec Business Overview
- 12.1.3 Chimera Biotec Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.1.4 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.1.5 Chimera Biotec Recent Developments
- 12.2 Reaction Biology
- 12.2.1 Reaction Biology Company Information
- 12.2.2 Reaction Biology Business Overview
- 12.2.3 Reaction Biology Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.2.4 Reaction Biology Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.2.5 Reaction Biology Recent Developments
- 12.3 NorthEast BioAnalytical Laboratories LLC
- 12.3.1 NorthEast BioAnalytical Laboratories LLC Company Information
- 12.3.2 NorthEast BioAnalytical Laboratories LLC Business Overview
- 12.3.3 NorthEast BioAnalytical Laboratories LLC Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.3.4 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.3.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
- 12.4 Creative Proteomics
- 12.4.1 Creative Proteomics Company Information
- 12.4.2 Creative Proteomics Business Overview
- 12.4.3 Creative Proteomics Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.4.4 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.4.5 Creative Proteomics Recent Developments
- 12.5 Pestka Biomedical Laboratories, Inc
- 12.5.1 Pestka Biomedical Laboratories, Inc Company Information
- 12.5.2 Pestka Biomedical Laboratories, Inc Business Overview
- 12.5.3 Pestka Biomedical Laboratories, Inc Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.5.4 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.5.5 Pestka Biomedical Laboratories, Inc Recent Developments
- 12.6 Precision Medicine Group, LLC
- 12.6.1 Precision Medicine Group, LLC Company Information
- 12.6.2 Precision Medicine Group, LLC Business Overview
- 12.6.3 Precision Medicine Group, LLC Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.6.4 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.6.5 Precision Medicine Group, LLC Recent Developments
- 12.7 CellCarta
- 12.7.1 CellCarta Company Information
- 12.7.2 CellCarta Business Overview
- 12.7.3 CellCarta Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.7.4 CellCarta Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.7.5 CellCarta Recent Developments
- 12.8 ImmunoDiagnostics Limited
- 12.8.1 ImmunoDiagnostics Limited Company Information
- 12.8.2 ImmunoDiagnostics Limited Business Overview
- 12.8.3 ImmunoDiagnostics Limited Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.8.4 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.8.5 ImmunoDiagnostics Limited Recent Developments
- 12.9 Alcyomics Ltd
- 12.9.1 Alcyomics Ltd Company Information
- 12.9.2 Alcyomics Ltd Business Overview
- 12.9.3 Alcyomics Ltd Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.9.4 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.9.5 Alcyomics Ltd Recent Developments
- 12.10 IMMUNOLOGIX
- 12.10.1 IMMUNOLOGIX Company Information
- 12.10.2 IMMUNOLOGIX Business Overview
- 12.10.3 IMMUNOLOGIX Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.10.4 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.10.5 IMMUNOLOGIX Recent Developments
- 12.11 Novogene
- 12.11.1 Novogene Company Information
- 12.11.2 Novogene Business Overview
- 12.11.3 Novogene Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.11.4 Novogene Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.11.5 Novogene Recent Developments
- 12.12 Guidon Pharmaceutics
- 12.12.1 Guidon Pharmaceutics Company Information
- 12.12.2 Guidon Pharmaceutics Business Overview
- 12.12.3 Guidon Pharmaceutics Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.12.4 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.12.5 Guidon Pharmaceutics Recent Developments
- 12.13 MEDx Translational Medicine Co., Ltd
- 12.13.1 MEDx Translational Medicine Co., Ltd Company Information
- 12.13.2 MEDx Translational Medicine Co., Ltd Business Overview
- 12.13.3 MEDx Translational Medicine Co., Ltd Revenue in Meso Scale Discovery (MSD) Assay Services Business (2021-2026)
- 12.13.4 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 12.13.5 MEDx Translational Medicine Co., Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst